drugset / Trial / NCT01021189

Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject

NCT01021189

Phase 1 Completed 97 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The primary aim of this study is to assess the safety and tolerability of AZD1446 following single and multiple ascending doses of an orally administered solution of AZD1446 in healthy young and elderly Japanese subjects.

Timeline

Start
2009-12
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1446 Small molecule Oral

Indications

No indication recorded.